HomeCompareLFEQ vs JNJ

LFEQ vs JNJ: Dividend Comparison 2026

LFEQ yields 0.96% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LFEQ wins by $1.0K in total portfolio value
10 years
LFEQ
LFEQ
● Live price
0.96%
Share price
$51.00
Annual div
$0.49
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.26
Full LFEQ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LFEQ vs JNJ

📍 LFEQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLFEQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LFEQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LFEQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LFEQ
Annual income on $10K today (after 15% tax)
$81.67/yr
After 10yr DRIP, annual income (after tax)
$86.92/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $616.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LFEQ + JNJ for your $10,000?

LFEQ: 50%JNJ: 50%
100% JNJ50/50100% LFEQ
Portfolio after 10yr
$20.5K
Annual income
$465.02/yr
Blended yield
2.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LFEQ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LFEQ buys
0
JNJ buys
0
No recent congressional trades found for LFEQ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLFEQJNJ
Forward yield0.96%3.36%
Annual dividend / share$0.49$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.0K$20.0K
Annual income after 10y$102.26$827.78
Total dividends collected$994.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LFEQ vs JNJ ($10,000, DRIP)

YearLFEQ PortfolioLFEQ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,796$96.08$10,676$355.77+$120.00LFEQ
2$11,649$96.94$11,407$389.39+$242.00LFEQ
3$12,562$97.75$12,198$426.53+$364.00LFEQ
4$13,540$98.52$13,056$467.62+$484.00LFEQ
5$14,587$99.24$13,987$513.12+$600.00LFEQ
6$15,708$99.92$14,998$563.56+$710.00LFEQ
7$16,908$100.56$16,098$619.52+$810.00LFEQ
8$18,193$101.16$17,295$681.69+$898.00LFEQ
9$19,568$101.73$18,599$750.82+$969.00LFEQ
10$21,040$102.26$20,022$827.78+$1.0KLFEQ

LFEQ vs JNJ: Complete Analysis 2026

LFEQStock

VanEck Long/Flat Trend ETF (LFEQ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Ned Davis Research CMG US Large Cap Long/Flat Index (NDRCMGLF). The NDRCMGLF Index follows a proprietary model that determines when, and by how much, it allocates to U.S. equities and/or U.S. Treasury bills to seek to help avoid losses in declining markets or capitalize from rising markets. The model produces daily trade signals to determine the Index's equity allocation percentage (100%, 50%, or 0%).

Full LFEQ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LFEQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LFEQ vs SCHDLFEQ vs JEPILFEQ vs OLFEQ vs KOLFEQ vs MAINLFEQ vs ABBVLFEQ vs MRKLFEQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.